Patel Sanj K

CIK 00015322185 companiesLONDON

SEC Profile

Transactions

Companies

Filings

CIK

0001532218

Recent Transactions

50 trades

Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+9,991→ 86,165 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+8,609→ 107,492 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+6,481→ 92,646 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01+30,050→ 30,050 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−8,609→ 25,826 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01$79.28/sh−15,144→ 92,348 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−9,991→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+6,237→ 98,883 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01$79.28/sh−15,144→ 92,348 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-09-01+120,150→ 120,150 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+6,237→ 98,883 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+8,609→ 107,492 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−6,481→ 6,481 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-09-01+120,150→ 120,150 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−6,237→ 12,475 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01+30,050→ 30,050 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−6,237→ 12,475 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−8,609→ 25,826 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+6,481→ 92,646 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-09-01+9,991→ 86,165 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−9,991→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-09-01−6,481→ 6,481 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-06-01+900,000→ 951,794 total
Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class B Ordinary Shares
2026-06-01−900,000→ 626,160 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-05-01$30.93/sh+48,565→ 48,565 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-05-01$54.02/sh−48,565→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-05-01−48,565→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-30$30.93/sh+2,141→ 2,141 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-04-30−2,141→ 48,565 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-30$54.01/sh−2,141→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-29$54.01/sh−22,544→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-04-29−22,544→ 50,706 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-29$30.93/sh+22,544→ 22,544 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$51.47/sh−113,673→ 295,346 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$30.93/sh+51,750→ 483,654 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$52.02/sh−243,596→ 51,750 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$54.02/sh−51,750→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$50.43/sh−74,635→ 409,019 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-28$10.36/sh+431,904→ 431,904 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-04-28−431,904→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-04-28−51,750→ 73,250 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-04-07−9,991→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-07+9,991→ 81,005 total
Tax Payment
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-07$48.94/sh−4,831→ 76,174 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-04-06−7,278→ 431,904 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-06$10.36/sh+7,278→ 7,278 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-04-06$50.01/sh−7,278→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-04-01−6,481→ 6,481 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-04-01−6,237→ 12,475 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Unit
2026-04-01−8,609→ 25,826 total

Companies

Recent Filings

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ

View on SEC.gov